+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

R

Actively Recruiting

Researchers are evaluating a digital program called Reaching Calm to prevent anxiety in pregnant women who may be at higher risk of anxiety during or after pregnancy. This pilot study focuses on the feasibility, acceptability, and early effectiveness of the program, which is delivered through obstetric care settings. Perinatal anxiety disorders affect many women and can lead to negative outcomes for families, so this study aims to improve accessibility to prevention through a tailored digital approach. The Reaching Calm program includes a digital Anxiety Sensitivity Intervention delivered via text messages and a web platform with psychoeducation and exposure exercises. Obstetric professionals receive training to support anxiety prevention and integrate the program into routine care. Four obstetric practices are randomized, with two offering Reaching Calm and two continuing usual prenatal care. The intervention and observation period lasts about four months to match typical prenatal care timelines. Participants will use text messages and web resources, complete surveys about symptoms and experiences, and some will join interviews or focus groups. The study tracks how many join and stay engaged, and assesses anxiety levels using several scales over baseline, 4 weeks, and 8 weeks. Healthcare professionals are surveyed and practice charts reviewed to evaluate implementation. Results will guide a larger trial to expand access to this digital anxiety prevention program for perinatal individuals.

Age: 18Years +FEMALEPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are evaluating the Thor system in adults aged 18 years and older who have new, untreated calcified blockages in leg arteries caused by peripheral artery disease PAD. The study aims to determine whether the Thor system is safe and effective for treating these lesions. Patients experience leg pain due to poor blood flow, and the study will observe how the Thor system works in this setting. All participants will receive treatment using the Thor laser atherectomy system, which targets calcified lesions to improve blood flow. During the procedure, doctors may also use additional devices such as angioplasty balloons, drug-coated balloons, stents, and clot-collecting filters if needed. The procedure includes x-ray imaging, and patients will be monitored closely until discharge or for up to 24 hours after treatment. Participants will have follow-up visits at discharge, 30 days, 6 months, and 12 months after the procedure. These visits include medical history reviews, physical exams of the legs, blood flow tests using arm and leg blood pressure comparisons, ultrasound imaging, and questionnaires about walking ability and quality of life. The study will measure outcomes such as freedom from major adverse events, procedural success, lesion openness, and improvements in walking and health surveys over one year.

Age: 18Years +All GendersPhase Not Applicable
29 locations